Thomas Stankovich is CFO at ReShape Lifesciences Inc. (RSLS). They have made 29 open-market trades across 2 companies since 2009, most recently 2024-05-31.
CIK 0001181166
8 open-market purchases totalling $209K since 2009, against 21 sales. Across 7 scored buys the stock is down 35.1% at ninety days, and 36.8 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 0% | 0% |
| Avg Move | -8.0% | -10.4% | -35.1% |
| Alpha | -7.1% | -8.3% | -36.8% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RSLS | SELL | 2023-11-30 | 2024-08-13 | $0.23 | $39 | -5.5% | -7.2% | -46.0% |
| RSLS | SELL | 2023-08-04 | 2023-11-08 | $0.89 | $386 | -2.9% | +5.3% | -17.9% |
| RSLS | SELL | 2023-07-06 | 2023-07-19 | $1.47 | $156 | -1.4% | -16.3% | -78.5% |
| RSLS | BUY | 2023-06-30 | 2023-07-06 | $1.52 | $27K | -2.7% | -2.8% | -77.7% |
| RSLS | SELL | 2023-03-31 | 2023-07-06 | $2.46 | $746 | -2.7% | -2.8% | -77.7% |
| RSLS | SELL | 2023-01-24 | 2023-03-07 | $8.87 | $4K | -30.4% | -28.0% | -34.6% |
| RSLS | SELL | 2022-11-28 | 2022-12-20 | $0.17 | $125K | +141.1% | +10.9% | -53.2% |
| RSLS | SELL | 2022-11-04 | 2022-11-10 | $0.27 | $2K | -22.6% | -29.1% | -47.5% |
| RSLS | SELL | 2022-10-04 | 2022-10-06 | $0.28 | $2K | -1.3% | -15.6% | -42.9% |
| RSLS | SELL | 2022-09-06 | 2022-09-12 | $0.39 | $2K | -22.9% | -30.5% | -62.0% |
| RSLS | SELL | 2022-08-05 | 2022-08-11 | $0.47 | $2K | -15.1% | -12.8% | -59.1% |
| RSLS | SELL | 2022-07-01 | 2022-07-06 | $0.55 | $3K | +0.4% | -11.7% | -42.8% |
| RSLS | SELL | 2022-06-01 | 2022-06-06 | $0.96 | $4K | -25.1% | -36.0% | -57.1% |
| RSLS | BUY | 2022-05-31 | 2022-06-01 | $0.92 | $18K | -23.8% | -40.7% | -53.4% |
| RSLS | SELL | 2022-05-05 | 2022-05-12 | $0.77 | $3K | +18.1% | +10.4% | -31.0% |
| RSLS | SELL | 2022-04-01 | 2022-04-08 | $1.13 | $6K | -10.9% | -41.2% | -50.1% |
| RSLS | SELL | 2022-02-28 | 2022-03-02 | $1.06 | $4K | -17.9% | +8.6% | -3.8% |
| RSLS | SELL | 2022-01-31 | 2022-02-02 | $1.22 | $4K | +5.2% | -9.6% | -28.9% |
| RSLS | SELL | 2022-01-04 | 2022-01-28 | $1.78 | $6K | +1.7% | -6.8% | -29.6% |
| RSLS | SELL | 2021-12-02 | 2021-12-09 | $1.83 | $8K | -1.0% | -25.5% | -51.2% |
| RSLS | BUY | 2021-11-18 | 2021-11-18 | $2.02 | $40K | -14.4% | -2.0% | -30.2% |
| RSLS | SELL | 2021-11-02 | 2021-11-16 | $2.69 | $12K | -9.6% | -3.7% | -44.7% |
| RSLS | SELL | 2021-10-01 | 2021-10-12 | $2.76 | $10K | -0.7% | -10.4% | -46.4% |
| RSLS | SELL | 2021-09-10 | 2021-09-17 | $2.89 | $280K | -8.9% | +3.8% | -28.0% |
| RSLS | BUY | 2021-08-30 | 2021-08-31 | $3.43 | $51K | -16.3% | -18.9% | -44.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.